Skip to main content
Log in

Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer

  • Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Introduction

Progesterone is the hormone of pregnancy and is required for its initiation. The actions of progesterone are mediated by the progesterone receptor. Polymorphic variants of human progesterone receptor genes have been implicated in implantation failure.

Materials and methods

We, therefore, investigated the prevalence of H770H(C/T genotype), V660L polymorphism and a 306 bp Alu insertion in exon 7 of the progesterone receptor among women with history of recurrent implantation failure to determine whether any of these polymorphisms may serve as a risk factor for implantation failure. DNA was extracted from the buccal swabs obtained from 66 women experiencing implantation failure and 75 fertile control women. PCR amplification of fragments was purified and the DNA sequenced to identify the polymorphism. The frequencies for the three variants were 27% for H770H, 21% for V660L and 0% for the 306 bp Alu insertion in exon 7 among women with implantation failure compared with control women of 25% for H770H and 24%for V660L and 0% for the 306 bp Alu insertion in exon 7.

Discussion

No significant differences in the overall allelic frequency of progesterone receptor variants was seen when women experiencing recurrent implantation failure were compared with control women.

Conclusion

We conclude that the H770H and V660L and PROGINS progesterone receptor polymorphisms are not markers that can identify women at risk for recurrent implantation after IVF/ET.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jones GS. The luteal phase defect. Fertil Steril 1976;27:351–56.

    PubMed  CAS  Google Scholar 

  2. Hoozemans DA, Schats R, Lambalk CB, Homburg R, Hompes PGA. Human embryo implantation: current knowledge and clinical implications in assisted reproductive technology. Reprod Biomed Online 2004;9:692–715.

    PubMed  Google Scholar 

  3. Pisarska MD, Carson SA, Casson PR, Tong X, Buster JE, Keiback DG. A mutated progesterone receptor allele is more prevalent in unexplained infertility. Fertil Steril 2003;80:651–3.

    Article  PubMed  Google Scholar 

  4. Cramer DW, Hornstein MD, McShane P, Powers RD, Lescault PJ, Vitonis AF, et al. Human progesterone polymorphisms and implantation failure during in vitro fertilization. Am J Obstet Gynecol 2002;189:1085–92.

    Article  CAS  Google Scholar 

  5. Rowe SM, Coughlan SJ, McKenna NJ, Garrett E, Kieback DG, Carney DN, et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 1995;55:2743–5.

    PubMed  CAS  Google Scholar 

  6. Kieback DG, Tong X-W, Weigel NL, Agoulnick IU. A genetic mutation in the progesterone receptor (PROGINS) leads to an increased risk of non-familial breast and ovarian cancer causing inadequate control of estrogen driven proliferation. J Soc Gynecol Invest 1998;5:40.

    Article  Google Scholar 

  7. Coulam CB. Implantation failure and immunotherapy. Hum Reprod 1995;10:1338–40.

    Article  PubMed  CAS  Google Scholar 

  8. Schweikert A, Rau T, Berkholtz A, Allera A, Daufeldt S, Wildt L. Association of progesterone receptor polymorphism with recurrent abortion. Eur J Obstet Gynecol Reprod Biol 2004;113:67–72.

    Article  PubMed  CAS  Google Scholar 

  9. Coulam CB, Jeyendran RS, Fishel LA, Roussev RG. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online 2006;12:322–7.

    Article  PubMed  Google Scholar 

  10. Kurz C, Tempfer CB, Boecskoer S, Unfried G, Nagele F, Hefler LA. The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Invest 2001;8:295–8.

    Article  CAS  Google Scholar 

  11. Coulam CB, Stephenson M, Stern JJ, Clark DA. Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod Immunol 1996;35:352–9.

    PubMed  CAS  Google Scholar 

  12. Fernandez-Valdivia R, Mukherjee A, Mulac-Jericevic B, Connely OM, De Mayo FJ, Amato P, et al. Revealing progesterone’s role in uterine and mammary gland biology: insights from the mouse. Semin Reprod Med 2005;23:22–37.

    Article  PubMed  CAS  Google Scholar 

  13. Urman B, Yakin K, Balaban B. Recurrent implantation failure in assisted reproduction: how to counsel and manage. A. General considerations and treatment options that may benefit the couple. Reprod Biomed Online 2005;11:371–81.

    PubMed  Google Scholar 

  14. Madon PF, Athalye P. Polymorphic variants on chromosomal probably play a significant role in infertility. Reprod Biomed Online 2005;11:726–32.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carolyn B. Coulam.

Additional information

Capsule

H770H, V660L and PROGINS progesterone receptor polymorphisms were not found to be associated with recurrent implantation failure after IVF/ET.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coulam, C.B., Jeyendran, R.S. & Roussev, R. Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer. J Assist Reprod Genet 25, 119–122 (2008). https://doi.org/10.1007/s10815-008-9210-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-008-9210-9

Keywords

Navigation